Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Addex Therapeutics (ADXN) Assets Average (2020 - 2025)

Addex Therapeutics' Assets Average history spans 6 years, with the latest figure at $8.6 million for Q4 2025.

  • On a quarterly basis, Assets Average fell 34.71% to $8.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.6 million, a 34.71% decrease, with the full-year FY2025 number at $9.9 million, up 14.02% from a year prior.
  • Assets Average came in at $8.6 million for Q4 2025, down from $9.7 million in the prior quarter.
  • The five-year high for Assets Average was $26.7 million in Q2 2021, with the low at $4.5 million in Q1 2024.
  • Historically, Assets Average has averaged $13.5 million across 5 years, with a median of $11.0 million in 2022.
  • Biggest five-year swings in Assets Average: plummeted 62.19% in 2023 and later soared 151.11% in 2025.
  • Year by year, Assets Average stood at $22.1 million in 2021, then tumbled by 51.78% to $10.6 million in 2022, then plummeted by 42.73% to $6.1 million in 2023, then skyrocketed by 115.35% to $13.1 million in 2024, then plummeted by 34.71% to $8.6 million in 2025.
  • Business Quant data shows Assets Average for ADXN at $8.6 million in Q4 2025, $9.7 million in Q3 2025, and $10.4 million in Q2 2025.